Month: July 2022

Corbion’s Supervisory Board announces it has nominated Olivier Rigaud for re-appointment as CEO and Chair of the Board of Management for a second term of office. Olivier Rigaud was appointed in 2019 and his current term of office runs from August 2019 to May 2023. Chair of the Supervisory Board Mathieu Vrijsen said: “The Supervisory Board is very pleased that Olivier is willing to extend his contract of assignment with Corbion for a second four-year term (May 2023 – May 2027). Since 2019, Olivier has been instrumental in the further development of Corbion into a leading innovative, sustainable solutions company, designing and successfully executing the Advance 2025 growth strategy, and strengthening Corbion’s commitment to the Preserve What Matters purpose. With his re-appointment we establish continuity in leadership to further...

13 July 2022 – Media Release Ad hoc announcement pursuant to Article 53 of SIX Exchange Regulation Listing Rules ONE swiss bank SA H1 2022 financial results (true & fair view) H1 2022 Financial Statements can be downloaded here.All documents are available on oneswissbank.com under “Investor relations” section. “One year ago, we had completed a promising merger and were finally seeing the light at the end of the pandemic tunnel. Along with this positive outlook, we launched several initiatives to harness new business opportunities. But since early 2022, we have encountered various headwinds – from the surge in new COVID variants, continued worldwide supply-chain disruptions and levels of inflation not seen for decades to the sudden unprecedented rate hikes by central banks (including the SNB’s upward nudge in its negative rate to close...

VANCOUVER, British Columbia, July 12, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a research, development, manufacturing corporation specializing in the commercialization of rare cannabinoids, announces that, as previously disclosed pursuant to a Form 8-K filed with the Securities Exchange Commission on June 21, 2022, the Company received written notice from the listing qualifications department staff of The Nasdaq Capital Market (“Nasdaq”) notifying it that the closing bid price of the Company’s common shares over a period of 30 consecutive trading days was below the minimum $1.00 per share requirement for continued listing on the Nasdaq under Nasdaq Listing Rule 5550(a)(2). In accordance with applicable Nasdaq procedures, the Company has a period of 180 calendar days following...

VANCOUVER, British Columbia, July 12, 2022 (GLOBE NEWSWIRE) — Icanic Brands Company Inc. (“Icanic” or the “Company”) (CSE: ICAN) announced today that the Supreme Court of British Columbia (the “Court”) has issued an interim order (the “Interim Order”) authorizing, among other things, the holding of a meeting (the “Meeting”) of holders (the “Secured Debentureholders”) of 9.00% secured convertible debentures (the “2019 Debentures”), to consider and vote upon a plan of arrangement (the “Plan of Arrangement”) to implement the previously-announced recapitalization transaction (the “Recapitalization Transaction”). The 2019 Debentures have been issued pursuant to a convertible debenture indenture dated June 6, 2019 (the “2019 Debenture Indenture”) between LEEF Holdings, Inc. (“LEEF”) and Odyssey Trust Company (“Odyssey”), as trustee and...

GAINESVILLE, Fla., and CAMBRIDGE, Mass., July 12, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), a clinical-stage biotechnology company focused on the development and commercialization of adeno-associated virus (AAV)-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases (IRDs), today announced the pricing of its previously announced underwritten public offering of 16,666,667 shares of its common stock (or common stock equivalents) and accompanying warrants to purchase up to 16,666,667 shares of common stock at a combined public offering price of $0.60 per share of common stock and accompanying warrant, less underwriting discounts and commissions. The warrants have an exercise price of $0.60 per share,...

GEORGE TOWN, Grand Cayman, July 12, 2022 (GLOBE NEWSWIRE) — O2Micro® International Limited (NASDAQ: OIIM), a global leader in the design, development and marketing of high-performance integrated circuits and solutions, will announce its financial results for the Second Quarter ending June 30, 2022, on Friday July 29, 2022. The press release will be followed by a conference call at 6:00 a.m. (US Pacific), 9:00 a.m. (US Eastern). You may participate using the following dial-in information: Participants, Int’l Toll: 1-412-317-6060Participants, US/CAN: 1-866-652-5200 A live webcast will also be available on the Company’s website at http://ir.o2micro.com, and an online replay will be available on the website for one week. The Call-in Audio Replay will be available following the call from July 29, 2022, at 12:00PM Eastern...